Advantages of chemotherapy and hypomethylating agents in myelodysplastic syndrome
Maria Teresa Voso
What are the differences in health technology assessment (HTA) across Europe?
How can clinicians and nurses care for patients with oral graft-versus-host disease (GvHD)?
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?
Is double autologous transplantation in multiple myeloma superior in the age of new agents?